RT MicroDx
RT MicroDx is a biotech company dedicated to revolutionizing healthcare by developing affordable, accurate, and accessible at-home molecular diagnostic solutions. Their mission is to empower individuals with control over their health through innovative testing technologies that address global health disparities, especially among underserved communities. The company focuses on creating simple, cost-effective, and reliable diagnostic tests that can be used at home, reducing the need for invasive procedures and long wait times, and integrating seamlessly with telehealth services.
Industries
Nr. of Employees
small (1-50)
Products
At-home saliva-based molecular test for Streptococcus A (strep throat)
A disposable over-the-counter molecular diagnostic kit that uses a saliva sample, isothermal amplification, and a lateral-flow strip readout to detect streptococcal infection with rapid results.
At-home saliva-based molecular test for Streptococcus A (strep throat)
A disposable over-the-counter molecular diagnostic kit that uses a saliva sample, isothermal amplification, and a lateral-flow strip readout to detect streptococcal infection with rapid results.
Services
Service design that pairs at-home sample collection and assay results with registration, remote consultation, and linkage to treatment via telehealth.
Service design that pairs at-home sample collection and assay results with registration, remote consultation, and linkage to treatment via telehealth.
Expertise Areas
- At-home molecular diagnostics
- Point-of-care testing
- Assay development and optimization
- Saliva sample formulation
Key Technologies
- Isothermal amplification (LAMP)
- Nucleic acid amplification
- Lateral-flow assay readout
- Saliva sample stabilization
News & Updates
RT MicroDx founder and CEO Nathalya Mamane will present at the Biotech Showcase conference in San Francisco, CA, to showcase their innovative at-home diagnostic platform.
Nathalya Mamane discussed the shift towards decentralized, point-of-care, and home-based testing, and how RT MicroDx is addressing healthcare accessibility.
An article providing strategies for biotech startups to secure funding, featuring insights from RT MicroDx.
A discussion on how RT MicroDx's innovative solutions aim to address health disparities among minority populations.
RT Microfluidics (now RT MicroDx) won the grand prize of $28,000 at Babson College's annual entrepreneurship competition for their at-home diagnostic platform.
RT Microfluidics achieved second place at MIT's prestigious $100K entrepreneurship competition with their innovative diagnostic technology.
RT MicroDx founder and CEO Nathalya Mamane will present at the Biotech Showcase conference in San Francisco, CA, to showcase their innovative at-home diagnostic platform.
Nathalya Mamane discussed the shift towards decentralized, point-of-care, and home-based testing, and how RT MicroDx is addressing healthcare accessibility.
An article providing strategies for biotech startups to secure funding, featuring insights from RT MicroDx.
A discussion on how RT MicroDx's innovative solutions aim to address health disparities among minority populations.
RT Microfluidics (now RT MicroDx) won the grand prize of $28,000 at Babson College's annual entrepreneurship competition for their at-home diagnostic platform.
RT Microfluidics achieved second place at MIT's prestigious $100K entrepreneurship competition with their innovative diagnostic technology.